Cardiac Fibrosis: Chronic Inflammatory Disease and Promising Therapeutic Target

Ryuji Okamoto1,2

  • 1Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan.

Insights

Understanding cardiac fibrosis is crucial for managing heart conditions like hypertrophy, heart failure, and arrhythmia. New research aims to uncover causes and treatments for these serious cardiac issues.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Fibrosis Research

Background:

  • Cardiac fibrosis is a key factor in managing cardiac hypertrophy, heart failure, and lethal arrhythmias.
  • Current understanding of cardiac fibrosis mechanisms and treatments remains incomplete.
  • Addressing cardiac fibrosis is essential for improving patient outcomes in cardiovascular diseases.

Discussion:

  • Investigating the underlying causes of cardiac fibrosis is paramount.
  • Elucidating the pathophysiologic mechanisms driving fibrosis is critical for therapeutic development.
  • Exploring novel treatment strategies for cardiac fibrosis is a significant clinical need.

Key Insights:

  • Improved comprehension of cardiac fibrosis is vital for effective clinical management.
  • Identifying new therapeutic targets for cardiac fibrosis can mitigate disease progression.
  • Advanced research into fibrosis mechanisms promises to unlock innovative treatment avenues.

Outlook:

  • Future research will focus on translating mechanistic insights into targeted therapies.
  • Enhanced understanding is expected to lead to improved patient prognoses.
  • Continued investigation into cardiac fibrosis will drive advancements in cardiovascular medicine.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
36
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
Inflammation01:38

Inflammation

Overview
54.9K